Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No other content changes.SummaryDifference0.1%

- Check71 days agoChange DetectedA new Revision: v3.4.2 banner was added and an older government funding/operating-status notice (v3.4.1) was removed, as a housekeeping update that does not affect study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedAdded a government funding lapse notice at the top of the page with guidance to visit cc.nih.gov and opm.gov for updates. Updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check85 days agoChange DetectedUI updates include a new 'Show glossary' option, capitalization tweaks (Last Update Submitted that Met QC Criteria vs met QC Criteria and No FEAR Act Data vs No FEAR Act data), and an updated Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.